1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-
|
|
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- 속성
- 끓는 점
- 402.8±18.0 °C(Predicted)
- 밀도
- 0.997±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 14.93±0.29(Predicted)
안전
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- C화학적 특성, 용도, 생산
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- 준비 용품 및 원자재
원자재
준비 용품
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- 공급 업체
글로벌( 33)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14336 | 58 |
CR Corporation Lomited | |
fred.wen@crcorporation.cn | CHINA | 12069 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3149 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8474 | 58 |
Shanghai Payne Pharmaceutical Technology Co.Ltd | 021-58123769 18678586262 |
info@paynepharm.com | China | 1354 | 58 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-52878169 15701683040 |
sales@bjcomparison.com | China | 4713 | 58 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15185 | 58 |
Gansu HaoTian Chemical Technology Co., Ltd. | 0943-6900332 17789447501 |
business02@gshtchem.com | China | 205 | 55 |
Zhengzhou Kangshan Biological Co., Ltd. | +86-0371-55023472 +86-13663848272 |
2584787837@qq.com | China | 182 | 58 |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 |
sales@feixiangpharm.com | China | 1008 | 58 |
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- 관련 검색:
2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol
PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy
lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth
ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)
carbamate
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
(3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis
((tert-butyldimethylsilyl)oxy)cyclohexylidene)
ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-
2,3-dimethylhept-4-en-2-ol
(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-
5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-
inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl
-6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl)
-7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-
((trimethylsilyl)oxy)hept-3-en-2-yl)-7a-
methyloctahydro-4H-inden-4-one
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept
-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one